Back to ALL Research Publications
PUBLICATION_
PUBLICATION_
PUBLICATION_
Research Category: ,
Lights, fluorescence, action—Influencing wound treatment plans including debridement of bacteria and biofilms
Related Publications
Related Material
PUBLICATION_ Routine fluorescence imaging to detect wound bacteria reduces antibiotic use and antimicrobial dressing expenditure while improving healing rates: Retrospective analysis of 229 foot ulcers
PUBLICATION_ Multidisciplinary Strategies With Real-Time Fluorescence Images and Negative Pressure Wound Therapy to Manage Organ/Space Surgical Site Infection in Transplanted Kidneys
PUBLICATION_ Assessing Pediatric Burn Wound Infection Using a Point-of-Care Fluorescence Imaging Device
MolecuLight Headquarters
425 University Avenue Suite 700 Toronto, ON M5G 1T6 Canada
US Address MolecuLight Corp. 2403 Sidney Street, Suite 286 Pittsburgh, PA 15203
T. 1-877-818-4360
North American Toll Free:
1-877-818-4360
F.+1 647-362-4730
E: info@moleculight.com
©2025
The MolecuLight® i:X and MolecuLightDX™ Imaging Devices are approved by Health Canada for sale in Canada and has CE marking for sale in the European Union.
The MolecuLight™ i:X and DX Imaging Devices have received FDA clearance.








